Differences in future life expectancy of testicular germ-cell tumor patients vs. age-matched male population-based controls.
Simone MorraMattia Luca PiccinelliCristina Cano GarciaStefano TapperoFrancesco BarlettaReha-Baris IncesuLukas ScheipnerAndrea BaudoZhe TianFred SaadVincenzo MironeGianluigi CalifanoClaudia Colla' RuvoloShahrokh F ShariatOttavio de CobelliGennaro MusiFelix K H ChunCarlo TerroneAlberto BrigantiDerya TilkiSascha AhyaiLuca CarmignaniNicola LongoPierre I KarakiewiczPublished in: International urology and nephrology (2023)
The OS difference between NS-TGCT patients vs. age-matched male population-based controls was invariably higher across all stages (2-22%) than for S-TGCT patients (1-11%). Reassuringly, OCM rates were marginal in stage I and stage II patients. Conversely, higher OCM rates were recorded in stage III patients.